BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29055141)

  • 1. Novel mutations in the LRP5 gene in patients with Osteoporosis-pseudoglioma syndrome.
    Pekkinen M; Grigelioniene G; Akin L; Shah K; Karaer K; Kurtoğlu S; Ekbote A; Aycan Z; Sağsak E; Danda S; Åström E; Mäkitie O
    Am J Med Genet A; 2017 Dec; 173(12):3132-3135. PubMed ID: 29055141
    [No Abstract]   [Full Text] [Related]  

  • 2. Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.
    Tüysüz B; Bursalı A; Alp Z; Suyugül N; Laine CM; Mäkitie O
    Horm Res Paediatr; 2012; 77(2):115-20. PubMed ID: 22456437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
    Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.
    Papadopoulos I; Bountouvi E; Attilakos A; Gole E; Dinopoulos A; Peppa M; Nikolaidou P; Papadopoulou A
    Eur J Pediatr; 2019 Mar; 178(3):323-329. PubMed ID: 30499050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Osteoporosis-pseudoglioma Syndrome: a pediatric case of primary osteoporosis].
    Braslavsky D; Scaglia P; Sanguineti N; Aza-Carmona M; Nevado Blanco J; Lapunzina Badia PD; Fernández MDC; Ruiz O; Carmona A; Szlago M; Arberas C; Cassinelli H; Heath K; Rey R; Bergadá I
    Arch Argent Pediatr; 2020 Jun; 118(3):e300-e304. PubMed ID: 32470270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis-pseudoglioma syndrome: Report of two cases and a manifesting carrier.
    Maltese P; Ziccardi L; Iarossi G; Gusson E; D'Agruma L; Marchini G; Buzzonetti L; Nicoletti A; Benedetti S; Bertelli M
    Ophthalmic Genet; 2017; 38(5):473-479. PubMed ID: 28145787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG).
    Celli M; D'Eufemia P; Persiani P; Turchetti A; Febbo A; D'Alfonso Y; Celli L; Zambrano A
    Osteoporos Int; 2017 Nov; 28(11):3277-3280. PubMed ID: 28866852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.
    Alonso N; Soares DC; V McCloskey E; Summers GD; Ralston SH; Gregson CL
    J Bone Miner Res; 2015 Apr; 30(4):615-20. PubMed ID: 25384351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable Expressivity and Response to Bisphosphonate Therapy in a Family with Osteoporosis Pseudoglioma Syndrome.
    Tallapaka KB; Ranganath P; Dalal A
    Indian Pediatr; 2017 Aug; 54(8):681-683. PubMed ID: 28891484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia.
    Ergun SG; Akay GG; Ergun MA; Perçin EF
    Eur J Med Genet; 2017 Mar; 60(3):200-204. PubMed ID: 28111184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital Bilateral Retinal Detachment in Two Siblings with Osteoporosis-Pseudoglioma Syndrome.
    Welinder LG; Robitaille JM; Rupps R; Boerkoel CF; Lyons CJ
    Ophthalmic Genet; 2015; 36(3):276-80. PubMed ID: 25945592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).
    Laine CM; Chung BD; Susic M; Prescott T; Semler O; Fiskerstrand T; D'Eufemia P; Castori M; Pekkinen M; Sochett E; Cole WG; Netzer C; Mäkitie O
    Eur J Hum Genet; 2011 Aug; 19(8):875-81. PubMed ID: 21407258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of LRP5 gene variants in a Chinese pedigree affected with Osteoporosis-pseudoglioma syndrome].
    Bai Z; Jiao Z; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Feb; 39(2):185-188. PubMed ID: 35076916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.
    Abdel-Hamid MS; Elhossini RM; Otaify GA; Abdel-Ghafar SF; Aglan MS
    Osteoporos Int; 2022 Jul; 33(7):1501-1510. PubMed ID: 35106624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the WNT Signaling Pathway for Clinical Purposes.
    Johnson ML; Recker RR
    Curr Osteoporos Rep; 2017 Jun; 15(3):153-161. PubMed ID: 28432596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP5, Bone Mass Polymorphisms and Skeletal Disorders.
    Littman J; Yang W; Olansen J; Phornphutkul C; Aaron RK
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta.
    Bardai G; Ward LM; Trejo P; Moffatt P; Glorieux FH; Rauch F
    Osteoporos Int; 2017 Jul; 28(7):2095-2101. PubMed ID: 28378289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray.
    Narumi S; Numakura C; Shiihara T; Seiwa C; Nozaki Y; Yamagata T; Momoi MY; Watanabe Y; Yoshino M; Matsuishi T; Nishi E; Kawame H; Akahane T; Nishimura G; Emi M; Hasegawa T
    Am J Med Genet A; 2010 Jan; 152A(1):133-40. PubMed ID: 20034086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imperfecta.
    Moosa S; Yamamoto GL; Garbes L; Keupp K; Beleza-Meireles A; Moreno CA; Valadares ER; de Sousa SB; Maia S; Saraiva J; Honjo RS; Kim CA; Cabral de Menezes H; Lausch E; Lorini PV; Lamounier A; Carniero TCB; Giunta C; Rohrbach M; Janner M; Semler O; Beleggia F; Li Y; Yigit G; Reintjes N; Altmüller J; Nürnberg P; Cavalcanti DP; Zabel B; Warman ML; Bertola DR; Wollnik B; Netzer C
    Am J Hum Genet; 2019 Oct; 105(4):836-843. PubMed ID: 31564437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.
    Barros ER; Dias da Silva MR; Kunii IS; Lazaretti-Castro M
    J Pediatr Endocrinol Metab; 2008 Aug; 21(8):811-8. PubMed ID: 18825883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.